Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Concentra Group Holdings Parent, Inc.CON · Entity 4001 | Director | November 04, 2025 | November 06, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Concentra Group Holdings Parent, Inc.
Report date November 04, 2025 · Filed November 06, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 74,000 |
Reported balance
After 2025-11-04 transaction · row 1
1 source rowRow 1 · 2025-11-04 · Grant · Acquired 7,748 · Balance 74,000 F1: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 4, 2026, the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 4, 2026, the first anniversary of the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SELECT MEDICAL HOLDINGS CORP
Report date June 30, 2026 · Filed July 01, 2026
Section 16 reporting ended · disclosed 2026-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Disposition to issuer · Disposed 80,035 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration"). F2: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration").
F2: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 1, 2026 18:23 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | Disposition to issuerCommon Stock | 80,035 | $16.50 | $1,320,577.50 |
DisclosureSEC source: 0001784668-26-000001 · form4-07012026_060746.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation, and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026). At the effective time of the merger, each of the Reporting Person's shares of common stock issued and outstanding immediately prior to the effective time of the merger was converted into the right to receive $16.50 per share in cash without interest ("Merger Consideration"). F2 · shares: Includes unvested shares of Company common stock subject to forfeiture conditions (the "Company Restricted Shares"). Pursuant the Merger Agreement, each Company Restricted Share held by the Reporting Person that was outstanding immediately prior to the effective time vested in full as of immediately prior to the effective time of the merger and was automatically converted into the right to receive the Merger Consideration, less any applicable tax withholdings. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 22:27 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | GrantCommon Stock | 7,748 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-107890 · tm2530505-6_4seq1.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 4, 2026, the first anniversary of the grant date. Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 21:38 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 14,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-020767 · form4-07312025_090726.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,035 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on July 29, 2026, the first anniversary of the grant date. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:21 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | GrantCommon Stock | 6,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027928 · form4-11292024_101105.xml · nonDerivative · entry 2 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,252 F2 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on November 26, 2025, the first anniversary of the grant date. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 22:21 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | GrantCommon Stock | 6,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027928 · form4-11292024_101105.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,796 F1 · kind: Grant of restricted stock which will vest in equal annual installments over five years. Read SEC document |
| November 25, 2024 Filed Nov 25, 2024 22:21 UTC | Concentra Group Holdings Parent, Inc. CON · Entity 4001 | OtherCommon Stock | 53,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-027654 · form4-11252024_101127.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,260 F1 · kind: The transactions reported herein are the result of the consummation on November 25, 2024 of the distribution of all the shares of common stock of Concentra Group Holdings Parent, Inc. by Select Medical Holdings Corporation ("Select") to holders of Select common stock on a pro rata basis. These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9. Read SEC document |
| April 30, 2024 Filed May 1, 2024 23:41 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-011925 · form4-05012024_110509.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,000 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on April 30, 2025, the first anniversary of the grant date. Read SEC document |
| August 01, 2023 Filed Aug 2, 2023 20:41 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-011756 · form4-08022023_080803.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,000 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 1, 2024, the first anniversary of the grant date. Read SEC document |
| August 01, 2022 Filed Aug 4, 2022 01:20 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-008224 · form4-08032022_060837.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,000 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 1, 2023, the first anniversary of the grant date. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:24 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-21-007957 · edgar.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on August 3, 2022, the first anniversary of the grant date. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 23:31 UTC | SELECT MEDICAL HOLDINGS CORP SEM · Entity 33845 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-20-008595 · edgar.xml · nonDerivative · entry 1 Thomas Daniel · CIK 0001784668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · kind: Grant of restricted stock which, subject to certain exceptions, will vest in full on July 28, 2021, the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.